Displaying drugs 526 - 550 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Gepirone | 359.474 C19H29N5O2 |  | A serotonin receptor agonist used to treat major depressive disorder in adults | Anti-Anxiety Agents / Serotonin Receptor Agonists |
| Deutetrabenazine | 323.466 C19H27NO3 |  | A vesicular monoamine transporter 2 inhibitor used for the symptomatic treatment of tardive dyskinesia and chorea associated with Huntington's disease. | Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Heterocyclic Compounds, Fused-Ring / Highest Risk QTc-Prolonging Agents / Nervous System / QTc Prolonging Agents / Quinolizines / Vesicular Monoamine Transporter 2 Inhibitor / Vesicular Monoamine Transporter 2 Inhibitors |
| Citicoline | 488.324 C14H26N4O11P2 |  | An endogenous intermediate in the formation of phosphatidylcholine from choline which is thought to have neuroprotective effects. | Cytidine Diphosphate / Nootropic Agents |
| Brincidofovir | 561.701 C27H52N3O7P |  | An oral lipid prodrug of cidofovir used in the treatment of human smallpox disease. | Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors |
| Erdafitinib | 446.555 C25H30N6O2 |  | A fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma. | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors |
| Gilteritinib | 552.724 C29H44N8O3 |  | An AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia. | Protein Kinase Inhibitors |
| Lorlatinib | 406.421 C21H19FN6O2 |  | An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors |
| Sultamicillin | 594.65 C25H30N4O9S2 |  | A mutual prodrug of ampicillin and sulbactam useful in the treatment of infections caused by beta-lactamase-producing bacteria. | Anti-Bacterial Agents |
| Vaborbactam | 297.13 C12H16BNO5S |  | A beta lactamase inhibitor used to treat complicated urinary tract infections. | beta-Lactamase Inhibitors |
| Mannitol busulfan | 338.34 C8H18O10S2 |  | Mm has been used in trials studying the treatment of Cocaine Dependence and Diabetes Mellitus, Type 2. | Agents causing hyperkalemia |
| Telotristat ethyl | 574.99 C27H26ClF3N6O3 |  | A tryptophan hydroxylase inhibitor that is used to treat carcinoid syndrome diarrhea. | Tryptophan Hydroxylase Inhibitor |
| Gadolinium | 157.25 Gd |  | Gadolinium is under investigation in Hypertension, ACUTE KIDNEY INJURY, and Chronic Kidney Disease. Gadolinium has been investigated for the basic science of CAD, Multiple Sclerosis, and Coronary Artery Disease. | Anti-Inflammatory Agents / Contrast Media / Lanthanoid Series Elements |
| Letermovir | 572.561 C29H28F4N4O4 |  | An antiviral medication used for prophylaxis in adult transplant recipients at risk of cytomegalovirus (CMV) infection and disease. | Antiviral Agents / Cytomegalovirus DNA Terminase Complex Inhibitor / Poly(ADP-ribose) Polymerase Inhibitors |
| Sarecycline | 487.509 C24H29N3O8 |  | A tetracycline antibiotic used to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris. | Anti-Bacterial Agents / Dermatologicals / Tetracyclines |
| Voxilaprevir | 868.94 C40H52F4N6O9S |  | A nonstructural protein 3 and 4a protease inhibitor used to treat Hepatitis C infections. | Antivirals for treatment of HCV infections |
| Tecovirimat | 376.335 C19H15F3N2O3 |  | An antiviral medication used to treat smallpox, monkeypox, and cowpox. | Anti-Infective Agents |
| Ponesimod | 460.97 C23H25ClN2O4S |  | A sphingosine 1-phosphate receptor modulator indicated to treat relapsing multiple sclerosis. | Selective Immunosuppressants / Sphingosine-1-phosphate (S1P) receptor modulators |
| Alpelisib | 441.47 C19H22F3N5O2S |  | Alpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor... | Phosphatidylinositol-3-kinase (Pi3K) inhibitors |
| Fostamatinib | 580.4595 C23H26FN6O9P |  | A spleen tyrosine kinase inhibitor used to treat chronic immune thrombocytopenia after attempting one other treatment. | Amines / BCRP/ABCG2 Inhibitors / Blood and Blood Forming Organs / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Experimental Unapproved Treatments for COVID-19 / Hemostatics / Kinase Inhibitor / Oxazines / Phosphodiesterase 5 Inhibitors / Pyridines / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors / UGT1A9 Substrates / Vasodilating Agents |
| Nirogacestat | 489.656 C27H41F2N5O |  | A gamma-secretase inhibitor used to treat desmoid tumors | Amyloid Precursor Protein Secretases, antagonists & inhibitors / Gamma Secretase Inhibitors and Modulators |
| Abemaciclib | 506.606 C27H32F2N8 |  | A medication used to treat HR+ HER2- advanced or metastatic breast cancer. | Cyclin-dependent kinase (CDK) inhibitors / Protein Kinase Inhibitors |
| Avatrombopag | 649.65 C29H34Cl2N6O3S2 |  | A thrombopoietin receptor agonist used pre-operatively to treat thrombocytopenia in patients with chronic liver disease and in patients with chronic refractory thrombocytopenia. | Receptors, Thrombopoietin, agonists |
| Diacerein | 368.297 C19H12O8 |  | An slow-onset anthraquinone IL-1 inhibitor used in the treatment of degenerative joint diseases like osteoarthritis. | Anti-Inflammatory Agents |
| Benznidazole | 260.253 C12H12N4O3 |  | A trypanocidal agent used to treat Chagas disease. | Nitroimidazole Derivatives |
| Entrectinib | 560.65 C31H34F2N6O2 |  | Entrectinib is indicated for the treatment of metastatic ROS1-positive non-small cell lung cancer in adults. Entrectinib is also indicated in adults and children over 12 years old for the treatment... | Protein Kinase Inhibitors |
Displaying drugs 526 - 550 of 2785 in total